Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

The effect of polymorphisms in candidate genes on the long-term risk of lipodystrophy and dyslipidemia in HIV-infected white patients starting antiretroviral therapy.

Marzocchetti A, Schwarz J, Di Giambenedetto S, Colafigli M, Bracciale L, Fabbiani M, Fantoni M, Trecarichi E, Cauda R, De Luca A.

AIDS Res Hum Retroviruses. 2011 Dec;27(12):1299-309. doi: 10.1089/aid.2010.0172. Epub 2011 Jun 20.

PMID:
21595566
2.

Contribution of 20 single nucleotide polymorphisms of 13 genes to dyslipidemia associated with antiretroviral therapy.

Arnedo M, Taffé P, Sahli R, Furrer H, Hirschel B, Elzi L, Weber R, Vernazza P, Bernasconi E, Darioli R, Bergmann S, Beckmann JS, Telenti A, Tarr PE; Swiss HIV Cohort Study.

Pharmacogenet Genomics. 2007 Sep;17(9):755-64.

PMID:
17700364
3.

No relationship between TNF-α genetic variants and combination antiretroviral therapy-related lipodystrophy syndrome in HIV type 1-infected patients: a case-control study and a meta-analysis.

Veloso S, Olona M, Peraire J, Viladés C, Pardo P, Domingo P, Asensi V, Broch M, Aguilar C, López-Dupla M, Aragonés G, Garcia-Pardo G, Sirvent JJ, Vendrell J, Richart C, Vidal F; Hiv Lipodystrophy Study Group.

AIDS Res Hum Retroviruses. 2011 Feb;27(2):143-52. doi: 10.1089/aid.2009.0312. Epub 2010 Sep 20.

PMID:
20854131
4.

Polymorphisms of the ApoE (Apolipoprotein E) gene and their influence on dyslipidemia in HIV-1-infected individuals.

Suwalak T, Srisawasdi P, Puangpetch A, Santon S, Koomdee N, Chamnanphon M, Charoenyingwattana A, Chantratita W, Sukasem C.

Jpn J Infect Dis. 2015;68(1):5-12. doi: 10.7883/yoken.JJID.2013.190. Epub 2014 Nov 25.

5.

Lipid-Lowering Therapy in HIV-Infected Patients: Relationship with Antiretroviral Agents and Impact of Substance-Related Disorders.

Bednasz C, Luque AE, Zingman BS, Fischl MA, Gripshover BM, Venuto CS, Gu J, Feng Z, DiFrancesco R, Morse GD, Ma Q.

Curr Vasc Pharmacol. 2016;14(3):280-7.

6.

Modeling the influence of APOC3, APOE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disorders.

Tarr PE, Taffé P, Bleiber G, Furrer H, Rotger M, Martinez R, Hirschel B, Battegay M, Weber R, Vernazza P, Bernasconi E, Darioli R, Rickenbach M, Ledergerber B, Telenti A; Swiss HIV Cohort Study.

J Infect Dis. 2005 May 1;191(9):1419-26. Epub 2005 Mar 22. Erratum in: J Infect Dis. 2005 Jun 1;191(11):1997.

7.

Polymorphisms in candidate genes and lipodystrophy and dyslipidemia.

Wiwanitkit V.

AIDS Res Hum Retroviruses. 2012 Jun;28(6):531. doi: 10.1089/AID.2011.0158. Epub 2012 Mar 23. No abstract available.

PMID:
22176158
8.

Leptin and adipose tissue maldistribution in HIV-infected male patients with predominant fat loss treated with antiretroviral therapy.

Estrada V, Serrano-Ríos M, Martínez Larrad MT, Villar NG, González López A, Téllez MJ, Fernández C.

J Acquir Immune Defic Syndr. 2002 Jan 1;29(1):32-40.

PMID:
11782587
9.

SNPs in the APM1 gene promoter are associated with adiponectin levels in HIV-infected individuals receiving HAART.

Trinca JR, Sprinz E, Lazzaretti RK, Hutz MH, Kuhmmer R, de Almeida S, Tibola A, Meirelles GB, Arena-de-Souza RC, Mattevi VS.

J Acquir Immune Defic Syndr. 2010 Nov;55(3):299-305.

PMID:
20964254
10.

Cardiac morbidity in an HIV-1 lipodystrophy patient cohort expressing the TNF-α-238 G/A single nucleotide gene polymorphism.

Mahajan SD, Gaekwad A, Pawar J, Tripathy S, Ghate M, Bhattacharya J, Singh HO, Schwartz SA, Paranjape R, Gangakhedkar R.

Curr HIV Res. 2015;13(2):98-108.

PMID:
25439236
11.

Serum adipocytokines are related to lipodystrophy and metabolic disorders in HIV-infected men under antiretroviral therapy.

Vigouroux C, Maachi M, Nguyên TH, Coussieu C, Gharakhanian S, Funahashi T, Matsuzawa Y, Shimomura I, Rozenbaum W, Capeau J, Bastard JP.

AIDS. 2003 Jul 4;17(10):1503-11.

PMID:
12824788
12.

Prevalence of lipodystrophy and dyslipidemia among patients with HIV infection on generic ART in rural South India.

Kalyanasundaram AP, Jacob SM, Hemalatha R, Sivakumar MR.

J Int Assoc Physicians AIDS Care (Chic). 2012 Sep-Oct;11(5):329-34. Epub 2011 Apr 20.

PMID:
21508297
13.

Alteration of tumor necrosis factor-alpha T-cell homeostasis following potent antiretroviral therapy: contribution to the development of human immunodeficiency virus-associated lipodystrophy syndrome.

Ledru E, Christeff N, Patey O, de Truchis P, Melchior JC, Gougeon ML.

Blood. 2000 May 15;95(10):3191-8. Erratum in: Blood 2000 Sep 1;96(5):1673.

14.

Lipodystrophy and insulin resistance in combination antiretroviral treated HIV-1-infected patients: implication of resistin.

Escoté X, Miranda M, Veloso S, Domingo P, Alonso-Villaverde C, Peraire J, Viladés C, Alba V, Olona M, Castro A, López-Dupla M, Sirvent JJ, Vicente V, Vendrell J, Richart C, Vidal F; HIV-1 Lipodystrophy Study Group.

J Acquir Immune Defic Syndr. 2011 May 1;57(1):16-23. doi: 10.1097/QAI.0b013e318213312c.

PMID:
21317795
15.

PPARgamma Pro12Ala polymorphism in HIV-1-infected patients with HAART-related lipodystrophy.

Saumoy M, Veloso S, Alonso-Villaverde C, Domingo P, Chacón MR, Miranda M, Aragonès G, Gutiérrez MM, Viladés C, Peraire J, Sirvent JJ, López-Dupla M, Aguilar C, Richart C, Vidal F; HIV Lipodystrophy Study Group.

Curr HIV Res. 2009 Sep;7(5):533-40.

PMID:
19534662
16.

Clinical review 153: Lipodystrophy in human immunodeficiency virus-infected patients.

Chen D, Misra A, Garg A.

J Clin Endocrinol Metab. 2002 Nov;87(11):4845-56. Review.

PMID:
12414837
17.

Contribution of genome-wide significant single-nucleotide polymorphisms and antiretroviral therapy to dyslipidemia in HIV-infected individuals: a longitudinal study.

Rotger M, Bayard C, Taffé P, Martinez R, Cavassini M, Bernasconi E, Battegay M, Hirschel B, Furrer H, Witteck A, Weber R, Ledergerber B, Telenti A, Tarr PE; Swiss HIV Cohort Study.

Circ Cardiovasc Genet. 2009 Dec;2(6):621-8. doi: 10.1161/CIRCGENETICS.109.874412. Epub 2009 Sep 18.

PMID:
20031643
18.

[Adipokines and highly active antiretroviral therapy related lipodystrophy: clinical study of 52 cases].

Tao MM, Zhang L, Qiu ZF, Xie J, Han Y, Yu W, Li M, Li TS.

Zhonghua Yi Xue Za Zhi. 2009 Apr 7;89(13):867-71. Chinese.

PMID:
19671283
19.

Relationship between polymerase gamma (POLG) polymorphisms and antiretroviral therapy-induced lipodystrophy in HIV-1 infected patients: a case-control study.

Chiappini F, Teicher E, Saffroy R, Debuire B, Vittecoq D, Lemoine A.

Curr HIV Res. 2009 Mar;7(2):244-53.

PMID:
19275594
20.

Impact of genetic factors on dyslipidemia in HIV-infected patients starting antiretroviral therapy.

Egaña-Gorroño L, Martínez E, Cormand B, Escribà T, Gatell J, Arnedo M.

AIDS. 2013 Feb 20;27(4):529-38. doi: 10.1097/QAD.0b013e32835d0da1.

PMID:
23262498

Supplemental Content

Support Center